Company Overview

West Pharmaceutical Services, Inc. is a global manufacturer of innovative containment and delivery systems for injectable drugs and healthcare products. The company operates within the pharmaceutical packaging, drug delivery, and medical device industries, serving primarily pharmaceutical, biotechnology, and generic drug manufacturers. Its core offerings focus on components and systems that ensure the safe storage, transfer, and administration of injectable therapies, including biologics, vaccines, and complex specialty drugs.

Founded in 1923, the company has evolved from a regional supplier of rubber components into a critical partner in the global injectable drug supply chain. West has built a strong competitive position through materials science expertise, high regulatory compliance standards, and long-standing customer relationships, particularly with large pharmaceutical companies developing high-value biologics and self-administered therapies.

Business Operations

West organizes its operations into two primary business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment generates the majority of revenue and includes elastomer components, stoppers, seals, and advanced drug delivery systems sold under West-owned technologies. The Contract-Manufactured Products segment focuses on custom formulation and manufacturing of elastomer components for pharmaceutical customers using customer-owned formulations.

The company operates manufacturing, research, and technical support facilities across multiple countries, supported by proprietary elastomer formulations, coating technologies, and integrated quality systems. West maintains a vertically integrated model covering material formulation, component manufacturing, and analytical services, enabling tight control over product performance and regulatory compliance. Its operations support both large-scale commercial drug production and clinical development programs.

Strategic Position & Investments

West’s strategy centers on expanding its high-margin Proprietary Products portfolio, investing in advanced materials, and supporting the growth of biologics, vaccines, and self-injection therapies. The company has made sustained capital investments in manufacturing capacity, automation, and analytical laboratories to support pharmaceutical customers facing increasingly complex regulatory and technical requirements.

Strategically, West has pursued targeted acquisitions and internal development initiatives to strengthen capabilities in drug containment, compatibility testing, and delivery systems. The company continues to invest in emerging technologies related to large-molecule drugs, sensitive biologics, and combination products, positioning itself as a long-term partner in the evolving injectable drug market rather than a commoditized component supplier.

Geographic Footprint

West is headquartered in North America and maintains a significant global presence across Europe, Asia-Pacific, and Latin America. Its manufacturing and technical support facilities are strategically located near major pharmaceutical production hubs to support regional customers and ensure supply chain resilience.

The company’s international operations enable it to serve multinational pharmaceutical companies consistently across continents, while also supporting local and regional drug manufacturers. West’s global footprint is designed to meet regulatory requirements in multiple jurisdictions and to provide redundancy and scalability for critical healthcare components.

Leadership & Governance

West is led by an experienced executive team with deep backgrounds in life sciences, advanced manufacturing, and global operations. Leadership emphasizes long-term value creation, operational excellence, disciplined capital allocation, and close collaboration with pharmaceutical customers to support innovation and regulatory compliance.

Key executives include:

• Eric M. Green – President and Chief Executive Officer
• Bernard J. Birkett – Senior Vice President and Chief Financial Officer
• Karen Greene – Senior Vice President, Chief Legal Officer and Corporate Secretary
• Silji Abraham – Senior Vice President and Chief Human Resources Officer
• Fran DeGrazio – Senior Vice President, Global Operations

The company is governed by an independent board of directors and follows established corporate governance practices consistent with U.S. public company standards.